UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Apple
AAPL
|
+$615M |
| 3 |
NVIDIA
NVDA
|
+$609M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.07B |
| 2 |
Tesla
TSLA
|
+$467M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$262M |
| 4 |
Match Group
MTCH
|
+$241M |
| 5 |
Valero Energy
VLO
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.89% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 6.45% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Communication Services | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Lesaka Technologies
LSAK
$402M
| $1.75M | ﹤0.01% |
349,210
-46,852
| -12% | -$222K |
|
4127
BlackRock Enhanced International Dividend Trust
BGY
$533M
| $1.74M | ﹤0.01% |
299,873
-14,193
| -5% | -$79.9K |
|
4128
Diodes
DIOD
$4.65B
| $1.74M | ﹤0.01% |
27,128
+9,688
| +56% | +$671K |
|
|
MYD
4129
DELISTED
BlackRock MuniYield Fund
MYD
| $1.74M | ﹤0.01% |
152,055
-26,389
| -15% | -$294K |
|
4130
Altimmune
ALT
$593M
| $1.73M | ﹤0.01% |
282,455
+122,854
| +77% | +$832K |
|
4131
PUT
State Street
STT
$51.3B
| $1.73M | ﹤0.01% |
19,600
| – | – |
|
4132
US Treasury 12 Month Bill ETF
OBIL
$307M
| $1.73M | ﹤0.01% |
34,371
+25,769
| +300% | +$1.29M |
|
4133
ArcBest
ARCB
$3.07B
| $1.73M | ﹤0.01% |
15,928
+4,885
| +44% | +$536K |
|
4134
CALL
Corsair Gaming
CRSR
$1.48B
| $1.73M | ﹤0.01% |
+248,000
| New | +$1.85M |
|
|
VSTO
4135
DELISTED
Vista Outdoor Inc.
VSTO
| $1.72M | ﹤0.01% |
44,019
+21,879
| +99% | +$848K |
|
|
RMI
4136
RiverNorth Opportunistic Municipal Income Fund
RMI
$101M
| $1.72M | ﹤0.01% |
105,561
-21,582
| -17% | -$346K |
|
4137
CALL
Louisiana-Pacific
LPX
$5.2B
| $1.72M | ﹤0.01% |
16,000
+1,000
| +7% | +$94.3K |
|
4138
iShares Global Financials ETF
IXG
$697M
| $1.72M | ﹤0.01% |
18,176
-1,194
| -6% | -$107K |
|
4139
CALL
Coupang
CPNG
$29.1B
| $1.72M | ﹤0.01% |
70,000
-278,100
| -80% | -$6.18M |
|
4140
RPC Inc
RES
$1.36B
| $1.72M | ﹤0.01% |
270,159
+237,274
| +722% | +$1.49M |
|
4141
Structure Therapeutics
GPCR
$3.82B
| $1.72M | ﹤0.01% |
39,080
+33,717
| +629% | +$1.3M |
|
|
VSXY
4142
CALL
Victoria's Secret
VSXY
$7.95B
| $1.71M | ﹤0.01% |
66,500
| – | – |
|
4143
Ollie's Bargain Outlet
OLLI
$4.8B
| $1.71M | ﹤0.01% |
17,573
-307
| -2% | -$29.6K |
|
|
FFC
4144
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$783M
| $1.71M | ﹤0.01% |
104,057
-481
| -0.5% | -$7.42K |
|
4145
CALL
Affirm
AFRM
$25.3B
| $1.71M | ﹤0.01% |
41,788
+31,748
| +316% | +$1.05M |
|
4146
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.95B
| $1.7M | ﹤0.01% |
29,530
-13,813
| -32% | -$769K |
|
4147
Gold Fields
GFI
$36.8B
| $1.7M | ﹤0.01% |
110,886
-18,188
| -14% | -$281K |
|
4148
Zymeworks
ZYME
$1.71B
| $1.7M | ﹤0.01% |
135,555
+9,881
| +8% | +$108K |
|
4149
Spyre Therapeutics
SYRE
$9.29B
| $1.7M | ﹤0.01% |
57,838
+13,334
| +30% | +$371K |
|
4150
Praxis Precision Medicines
PRAX
$10.2B
| $1.7M | ﹤0.01% |
29,550
+2,773
| +10% | +$150K |
|
Similar funds
UBS Group's Q3 2024 Portfolio in Review
As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS Group deployed $30.4B of net new capital in Q3 2024, opening 1,098 new positions and adding to 4,837 existing holdings. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Nike, an estimated $1.07B trimmed.
- UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
- UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
- UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
- UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
- UBS Group opened 1,098 new positions and closed 1,108 in Q3 2024.
- UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.